CHL Healthcare Partners is an investment firm focused on starting and growing successful healthcare businesses. Over the past 15 years, the principals of the firm, Jeff Collinson, Myles Greenberg, M.D., Tim Howe, and Greg Weinhoff, M.D., have invested in many successful healthcare services start-up companies, including American Renal Associates (sold to Wachovia Capital Partners), Ascend Health Corporation (sold to Universal Health Services - NYSE: UHS), Camitro Corporation (sold to Arqule – NASDAQ: ARQL), Genomic Health (NASDAQ: GHDX), Medicus (sold to NORCAL Mutual Insurance Co.), Odyssey Healthcare, Inc. (NASDAQ: ODSY, later sold to Gentiva – NASDAQ: GTIV), and Sempercare, Inc. (sold to Select Medical – NYSE: SEM). Current active healthcare services portfolio companies include CareWell Urgent Care Centers of New England, Inc., Comprehensive Clinical Development, Inc., Dicom Grid, Inc., Ella Health, Inc., Fidelis SeniorCare, Inc., Millennium Pharmacy Systems, Inc., and Medmark Services, Inc. In all of these companies, the CHL Healthcare Partners’ principals were founding or among the first institutional investors.

The healthcare services market is $2.2 trillion in the U.S. and consists of many compelling sectors in which to start and grow successful new businesses. We are actively seeking such early-stage investment opportunities for CHL Healthcare Partners.

The principals of CHL Healthcare Partners also continue to manage the CHL Medical Partners funds. These funds are now fully committed.